Saturday, April 15, 2017 11:15:49 PM
I agree with other buyers that USRM would be a great buyout target. It's a tiny company with big potential. Some competitors probably see USRM as a chance to expand their existing business. Others might view a buyout as a cheap way to eliminate a threat to their drug revenue. I'd prefer the first type of buyout because I'd hate to see stem cell treatments and equipment patents being purchased and hidden from patients who could benefit. Just my thoughts.
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM